We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current HROW market cap is 371.55M. The company's latest EPS is USD -0.6951 and P/E is -35.71.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 22.82M | 20.33M | 26.1M | 33.47M | 34.27M |
| Operating Income | -3.6M | -3.88M | 1.21M | 2.2M | 1.74M |
| Net Income | -6.46M | 1.06M | -6.64M | -4.23M | -4.39M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 51.17M | 48.87M | 72.48M | 88.6M | 130.19M |
| Operating Income | -763k | 385k | 1.61M | -9.21M | 431k |
| Net Income | 168k | -3.36M | -18.01M | -14.09M | -24.41M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 98.99M | 157.38M | 217.5M | 223.99M | 286.07M |
| Total Liabilities | 98.13M | 130.14M | 195.97M | 201.94M | 210.66M |
| Total Equity | 862k | 27.24M | 21.53M | 22.05M | 75.4M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 59.09M | 57.47M | 98.33M | 157.38M | 312.16M |
| Total Liabilities | 31.67M | 30.65M | 87.4M | 130.14M | 241.75M |
| Total Equity | 27.42M | 26.83M | 10.93M | 27.24M | 70.41M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 5.42M | 1.71M | -8.21M | -3.65M | -4.86M |
| Investing | -1.74M | -1.74M | -130.97M | -132.22M | -152.35M |
| Financing | -887k | 54.14M | 62.16M | 62.35M | 126.55M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 950k | -1.1M | 5.08M | 1.71M | 3.84M |
| Investing | -1.83M | -981k | -18.69M | -1.74M | -152.55M |
| Financing | -1.01M | 1.43M | 51.47M | 54.14M | 126.53M |
| Market Cap | 371.55M |
| Price to Earnings Ratio | -35.71 |
| Price to Sales Ratio | 6.69 |
| Price to Cash Ratio | 11.77 |
| Price to Book Ratio | 12.38 |
| Dividend Yield | - |
| Shares Outstanding | 35.12M |
| Average Volume (1 week) | 497.34k |
| Average Volume (1 Month) | 420.07k |
| 52 Week Change | -58.20% |
| 52 Week High | 28.25 |
| 52 Week Low | 7.60 |
| Spread (Intraday) | 0.02 (0.19%) |
| Company Name | Harrow Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.harrow.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
